Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 2 Chemotherapy Regimens in Relapsed NSCLC
NCT00535275Phase 3Terminated
- Sponsor
- IFCT
- Start
- Sep 2007
- Primary completion
- Nov 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin, carboplatin in non-small cell lung cancer (NSCLC), sponsored by IFCT. Started Sep 2007; status: terminated.
02
Drugs
cisplatincarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00535275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535275.